A Successful Liver Transplantation for Refractory Hepatic Veno‐Occlusive Disease Originating from Cord Blood Transplantation
Open Access
- 1 September 2002
- journal article
- case report
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 2 (8), 796-800
- https://doi.org/10.1034/j.1600-6143.2002.20815.x
Abstract
An 11‐month‐old boy with acute lymphoblastic leukemia (ALL) underwent umbilical cord blood transplantation (CBT) from an unrelated donor after a first complete remission. Despite the prophylactic use of low molecular weight heparin, prostaglandin E1 and ursodeoxycholic acid, hepatic veno‐occlusive disease (VOD) occurred on the 29th day after CBT. Furthermore, neither defibrotide nor antithrombin‐III improved the hepatic coma and coagulopathy due to the hepatic VOD. On the 42nd day after CBT, he underwent living related liver transplantation (LRLT) with a left lateral segment graft from his father. He received tacrolimus for the prevention of rejection and graft‐vs.‐host disease (GVHD) and also received aggressive antifungal and antiviral prophylaxis. Although he showed signs of acute rejection on postoperative days 5 and 10, the postoperative course was uneventful in general. At present, 17 months after LRLT, the patient shows stable liver function and no signs of either GVHD or a relapse of ALL. In conclusion, LRLT can be seen as a feasible option for the treatment of a hepatic VOD after CBT, though aggressive prophylaxis for infection and the anticipation of acute rejection are of importance.Keywords
This publication has 17 references indexed in Scilit:
- Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: incidence, onset time and risk factorsBone Marrow Transplantation, 1998
- ORTHOTOPIC LIVER TRANSPLANTATION FOR VENO-OCCLUSIVE DISEASE COMPLICATING AUTOLOGOUS BONE MARROW TRANSPLANTATIONTransplantation, 1997
- Treatment of Hepatic Venocclusive Disease With Recombinant Human Tissue Plasminogen Activator and Heparin in 42 Marrow Transplant PatientsBlood, 1997
- TREATMENT OF HEPATIC VENOOCCLUSIVE DISEASE WITH RECOMBINANT HUMAN TISSUE PLAMINOGEN ACTIVATOR OR ORTHOTOPIC LIVER TRANSPLANTATION AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION1Transplantation, 1996
- RELATED DONOR LIVER TRANSPLANT FOR VENO-OCCLUSIVE DISEASE FOLLOWING T-DEPLETED UNRELATED DONOR BONE MARROW TRANSPLANTATIONTransplantation, 1996
- HEPATIC REJECTION AFTER ORTHOTOPIC LIVER TRANSPLANTATION FOR HEPATIC VENO-OCCLUSIVE DISEASE OR GRAFT-VERSUS-HOST DISEASE FOLLOWING BONE MARROW TRANSPLANTATIONTransplantation, 1995
- Veno-occlusive Disease of the Liver and Multiorgan Failure after Bone Marrow Transplantation: A Cohort Study of 355 PatientsAnnals of Internal Medicine, 1993
- SUCCESSFUL TREATMENT OF HEPATIC VENOOCCLUSIVE DISEASE IN A BONE MARROW TRANSPLANT PATIENT WITH ORTHOTOPIC LIVER TRANSPLANTATIONTransplantation, 1990
- VENOOCCLUSIVE DISEASE OF THE LIVER FOLLOWING BONE MARROW TRANSPLANTATIONTransplantation, 1987
- Venocclusive Disease of the Liver after Bone Marrow Transplantation: Diagnosis, Incidence, and Predisposing FactorsHepatology, 1984